Pickhardt, Perry J.
Funding for this research was provided by:
National Cancer Institute (1R01CA155347, 1R01CA169331)
Article History
First Online: 3 June 2016
Compliance with ethical standards
:
: Co-founder of VirtuoCTC, shareholder in SHINE, Elucent, and Cellectar Biosciences.
: None.
: None.